Skip to main content
. 2020 May 6;10(5):233. doi: 10.1007/s13205-020-02232-2

Table 2.

Discharge parameters behaviour of different cycles of CLWW treatment (1500.00 CU) with P. pastoris X33/pGAPZαA-LaccPost-Stop (Clone 1) immobilized of the cells

Discharge parameter 0 h 74 h Removal (%)
Cycle 1
 TOC (mg L−1) 2214.26 ± 46.84 591.97 ± 3.63 73.26 ± 0.40
 TC (mg L−1) 2290.00 ± 48.08 608.50 ± 4.38 73.42 ± 0.37
 IC (mg L−1) 75.74 ± 1.24 16.53 ± 0.75 78.18 ± 0.64
 TN (mg L−1) 411.49 ± 20.53 264.40 ± 4.81 36.49 ± 5.00
 CU 1500.00 ± 0.00 12.63 ± 2.19 99.16 ± 0.15a
 COD (mg L−1) 6045.00 ± 35.36 1660.00 ± 0.00 72.43 ± 0.00
 BOD5 (mg L−1) 999.00 ± 0.00 999.00 ± 0.00 0.00 ± 0.00
 TSS (mg L−1) 275.00 ± 35.36 50.00 ± 0.00 80.00 ± 0.00
 BOD5/COD 0.16 0.60 N/A
 TOC/TN 5.38 2.24 N/A
 COD/TOC 2.73 2.80 N/A
 pH 4.16 ± 0.20 5.05 ± 0.20 N/A
Cycle 2
 TOC (mg L−1) 135.86 ± 6.70 74.01 ± 0.50 45.45 ± 3.06
 TC (mg L−1) 165.09 ± 3.97 93.22 ± 1.22 43.36 ± 2.65
 IC (mg L−1) 29.11 ± 0.93 19.36 ± 0.57 33.49 ± 0.19
 TN (mg L−1) 94.76 ± 1.63 93.20 ± 0.62 2.17 ± 1.32
 CU 1500.00 ± 0.00 6.31 ± 4.37 99.58 ± 0.29a
 COD (mg L−1) 760.00 ± 155.56 280.00 ± 14.14 67.82 ± 1.63
 BOD5 (mg L−1) 999.00 ± 0.00 250.00 ± 0.00 74.98 ± 0.00
 TSS (mg L−1) 66.67 ± 28.87 66.67 ± 28.87 0.00 ± 0.00
 BOD5/COD 1.30 0.80 N/A
 TOC/TN 1.43 0.79 N/A
 COD/TOC 5.59 3.78 N/A
 pH 7.21 ± 0.20 8.01 ± 0.20 N/A
Cycle 3
 TOC (mg L−1) 47.08 ± 1.41 20.60 ± 3.13 56.13 ± 7.96
 TC (mg L−1) 54.22 ± 2.17 27.81 ± 1.54 48.61 ± 4.59
 IC (mg L−1) 6.33 ± 0.73 7.34 ± 0.85 0.00 ± 0.00
 TN (mg L−1) 60.07 ± 0.66 60.60 ± 0.00 0.00 ± 0.00
 CU 1500.00 ± 0.00 10.10 ± 2.19 99.33 ± 0.15a
 COD (mg L−1) 370.00 ± 0.00 295.00 ± 21.21 15.71 ± 6.06
 BOD5 (mg L−1) 250.00 ± 0.00 250.00 ± 0.00 0.00 ± 0.00
 TSS (mg L−1) 166.67 ± 28.87 33.33 ± 28.87 83.33 ± 14.43
 BOD5/COD 0.60 0.80 N/A
 TOC/TN 0.78 0.34 N/A
 COD/TOC 7.86 14.32 N/A
 pH 7.28 ± 0.20 7.50 ± 0.20 N/A

N/A does not apply, N/C unable to calculate

aPercentage calculated from 1500.00 CU at the beginning of treatment